AMP-activated protein kinase (AMPK) regulates energy homeostasis and immune responses, making it a key target for immunometabolic disorders like obesity, insulin resistance, and neurodegenerative diseases. The gene discussed is PRKAA1; the disease is obesity due to melanocortin 4 receptor deficiency.